MolPort
Riga · Founded 2006
About MolPort
MolPort sells existing chemical compounds to biotech researchers and the scientific community to speed up drug discovery. Whether it is for biological testing or a reagent to make a key target compound, effectively accessing commercial compounds is a core component of efficient drug discovery. MolPort was created in 2006 to help scientists accelerate drug discovery by handling the ordering process of screening compounds and building blocks. Our goal is to help scientists focus on their research, not on procurement. Compound sourcing is a very specific job that requires very specialized expertise and software tools. MolPort specializes in sourcing hundreds or thousands of compounds from dozens of suppliers.
Company Facts
- Founded: 2006
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $1.3M
- Last round: Series Unknown (Jun 2015)
- Website: http://www.molport.com
- Phone: 371 67 790 398
Social Profiles
Canonical: https://fsome.com/organization/molport-8322802 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.